Data as of Dec 19
| +0.38 / +7.10%|
The 2 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 10.50, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +83.25% increase from the last price of 5.73.
The current consensus among 2 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.